Frequent dosing and GPNMB expression with CDX-011 (CR011-vcMMAE), an antibody-drug conjugate (ADC), in patients with advanced melanoma.
Hamid O, Sznol M, Pavlick A, Kluger H, Kim K, Boasberg P, Simantov R, Davis T, Crowley E, Hwu P. Frequent dosing and GPNMB expression with CDX-011 (CR011-vcMMAE), an antibody-drug conjugate (ADC), in patients with advanced melanoma. Journal Of Clinical Oncology 2010, 28: 8525-8525. DOI: 10.1200/jco.2010.28.15_suppl.8525.Peer-Reviewed Original Research